At VisionQuest i-Rx, our goal is to revolutionize diabetic retinopathy screening through novel software automation so that only patients in need of specialty care are referred to an ophthalmologist.

Our novel EYESTAR™ automated screening system is built on a sophisticated, yet operationally simple software technology platform that employs a patented top-down algorithm that instantly screens patients as either a “refer” or “non-refer” without the need for annotation of images for retinal pathology. Patients identified as “refer” are referred to an ophthalmologist for comprehensive eye examinations.

The EYESTAR™ system has demonstrated a high sensitivity (>95%) and high specificity (>70%) for detection of actionable stages of diabetic retinopathy.

The EYESTAR™ software can be adapted to most retinal cameras currently on the market. Additionally, the EYESTAR™ system can be used to detect other retinal diseases. Future generations of our system will incorporate screening of hypertensive retinopathy, glaucoma, and age-related macular degeneration, all of which are common diseases found in those with diabetes.